Recent advances in understanding chemotherapy-induced peripheral neuropathy

Chemotherapy-induced peripheral neuropathy (CIPN) is a common cause of pain and poor quality of life for those undergoing treatment for cancer and those surviving cancer. Many advances have been made in the pre-clinical science; despite this, these findings have not been translated into novel preven...

Descripción completa

Detalles Bibliográficos
Autores principales: Gordon-Williams, Richard, Farquhar-Smith, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076330/
https://www.ncbi.nlm.nih.gov/pubmed/32201575
http://dx.doi.org/10.12688/f1000research.21625.1
_version_ 1783507193651265536
author Gordon-Williams, Richard
Farquhar-Smith, Paul
author_facet Gordon-Williams, Richard
Farquhar-Smith, Paul
author_sort Gordon-Williams, Richard
collection PubMed
description Chemotherapy-induced peripheral neuropathy (CIPN) is a common cause of pain and poor quality of life for those undergoing treatment for cancer and those surviving cancer. Many advances have been made in the pre-clinical science; despite this, these findings have not been translated into novel preventative measures and treatments for CIPN. This review aims to give an update on the pre-clinical science, preventative measures, assessment and treatment of CIPN.
format Online
Article
Text
id pubmed-7076330
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher F1000 Research Limited
record_format MEDLINE/PubMed
spelling pubmed-70763302020-03-20 Recent advances in understanding chemotherapy-induced peripheral neuropathy Gordon-Williams, Richard Farquhar-Smith, Paul F1000Res Review Chemotherapy-induced peripheral neuropathy (CIPN) is a common cause of pain and poor quality of life for those undergoing treatment for cancer and those surviving cancer. Many advances have been made in the pre-clinical science; despite this, these findings have not been translated into novel preventative measures and treatments for CIPN. This review aims to give an update on the pre-clinical science, preventative measures, assessment and treatment of CIPN. F1000 Research Limited 2020-03-11 /pmc/articles/PMC7076330/ /pubmed/32201575 http://dx.doi.org/10.12688/f1000research.21625.1 Text en Copyright: © 2020 Gordon-Williams R and Farquhar-Smith P http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Gordon-Williams, Richard
Farquhar-Smith, Paul
Recent advances in understanding chemotherapy-induced peripheral neuropathy
title Recent advances in understanding chemotherapy-induced peripheral neuropathy
title_full Recent advances in understanding chemotherapy-induced peripheral neuropathy
title_fullStr Recent advances in understanding chemotherapy-induced peripheral neuropathy
title_full_unstemmed Recent advances in understanding chemotherapy-induced peripheral neuropathy
title_short Recent advances in understanding chemotherapy-induced peripheral neuropathy
title_sort recent advances in understanding chemotherapy-induced peripheral neuropathy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076330/
https://www.ncbi.nlm.nih.gov/pubmed/32201575
http://dx.doi.org/10.12688/f1000research.21625.1
work_keys_str_mv AT gordonwilliamsrichard recentadvancesinunderstandingchemotherapyinducedperipheralneuropathy
AT farquharsmithpaul recentadvancesinunderstandingchemotherapyinducedperipheralneuropathy

Ejemplares similares